News
It won't come to fruition for quite some time, but plans are afoot to create a Mount Gilead Park in Centreville's Historic District. Two representatives of the Fairfax County Park Authority ...
A New York doctor who treated HIV and AIDS patients sued Gilead for violating the False Claims Act with payments to doctors who spoke at sponsored events.
Biopharmaceutical company Gilead Sciences (NASDAQ:GILD) will be announcing earnings results tomorrow afternoon. Here’s what you need to know.
Pharmaceutical stock Gilead Sciences Inc (NASDAQ:GILD) is down 2.6% at $107.34, after news that domestic HIV prevention is under review by the Trump administration, and the Health and Human ...
Gilead's dominance in HIV faces Medicare pricing challenges, limiting growth.
The Morrow County Democratic Party will meet Wednesday, Feb. 19, at 7 p.m. at the Mt Gilead Library Annex. People are invited to begin gathering at 6:30 p.m. All are welcome to attend. New nonprofit ...
Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs Truvada and Descovy, according to a Wednesday filing in Delaware federal court.
TM received consulting fees from Eisai, Gilead Sciences; honoraria from Eisai, AbbVie, Eli Lilly, Gilead Sciences, Asahi Kasei. KS received grants/research support from Novartis, Astellas, AbbVie, ...
Gilead missed revenue estimates with its latest quarter and issued underwhelming 2024 guidance.
Arcus and Gilead are rethinking their TIGIT strategy, stopping a phase 3 lung cancer TIGIT clinical trial and walking away from another project.
Gilead’s general counsel, Deb Telman, said in a statement that the jury’s verdict confirmed the company’s “longstanding belief” that it has always had the rights to the drugs for PrEP.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results